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MANUSCRIPT 
The ultimate goal of orthodontic research is the effective dissemination of new findings to the wider 
community. However, studies published in scientific journals are often compromised by incomplete reporting 
that can minimise their potential impact by compromising appropriate critical appraisal by the reader, 
replication by other research teams or inclusion in meta-research. Typical examples include studies that fail 
to report baseline characteristics of included subjects and standard deviations for continuous outcomes; or 
those that report percentages of patients with an event of interest at multiple time-points, without reporting 
the effective sample at each time-point. 
 From the reader’s point-of-view, not having all the required information compromises our ability to 
critically appraise the research findings in terms of magnitude, applicability and, ultimately, clinical 
relevance. 
From the researcher’s point-of-view, a lack of data needed to include a study in a meta-analysis 
means that this study will ultimately not contribute to the evidence-base. The meta-analyst retains the 
option to contact a corresponding author and request the missing data, but unfortunately in the vast 
majority of cases the authors either do not respond at all or they cannot provide the data for a variety of 
reasons. Moreover, it is important to note that although raw measurements taken during a study and the 
calculated descriptive statistics are objective data, any statistical analysis used to draw inferences between 
two or more variables always carries a degree of subjectivity. In other words, the same data might be 
analysed by two persons differently, without either necessarily being wrong. 
Finally, from a patient’s point-of-view, all those who agree to take part in clinical research do so on 
the basis that this research is carried out and reported to the highest standard and will further existing 
knowledge in the field, ultimately benefitting the patient community through more effective and efficient 
patient care. When we, even inadvertently, hold back on such potentially useful information we do our 
patients a great disservice, by not fulfilling our ethical obligations as researchers. 
There is a growing movement in the scientific community to encourage reproducibility and 
transparency practices within the scientific community, including public access to protocols and raw data, 
the conduct of replication studies, systematic integration of evidence in systematic reviews and the 
documentation of funding and potential conflicts of interest (Iqbal et al. 2016). 
 
What can be done 
The International Committee of Medical Journal Editors (ICMJE) believes there is an ethical obligation to 
responsibly share data generated by clinical research, and especially interventional clinical trials because 
patients have put themselves at risk. The ICMJE proposes to require authors to share with others the de-
identified individual-patient data underlying the results presented in any article (including tables, figures, 
and appendices or supplementary material) no later than 6 months after publication. The data underlying 
the results are defined as the individual-patient data required to reproduce the article's findings. Therefore, 
ICMJE requires the following as conditions for consideration of publication of a clinical study report in its 
member journals: As of 1 July 2018 manuscripts submitted to ICMJE journals that report the results of 
clinical research must contain a data sharing statement (Taichman et al. 2017); and clinical trials that begin 
enrolling participants on or after 1 January 2019 must include a data sharing plan in the trial registration 
(including their ClinicalTrials.gov protocol), including ethical committee approval and patient informed 
consent. Many journals have now adopted data sharing policies and whilst these are not yet strongly 
enforced, others maintain more stringent requirements for data sharing (Alsheikh-Ali et al. 2012). 
 
Points to consider 
Just as patient confidentiality must be protected (through de-identification of the dataset) so must the 
reasonable rights of researchers and sponsors be protected. The ICMJE has proposed the following 
measures for this: ICMJE editors will not consider data deposition in a repository as prior publication; the 
authors of secondary analyses must attest that this use is in accordance with the terms (if any) agreed to 
upon their receipt; authors of secondary analyses must reference the source of the data using a unique 
DOI of a study dataset to provide appropriate credit to those who generated it (and allow searching for the 
studies it has supported); and authors of secondary analyses must explain completely how theirs differs 
from previous analyses, if it does. In addition, those who generate and then share clinical trial data-sets 
deserve substantial credit for their efforts. Efforts are currently placed towards devising appropriate credit 
or recognition systems in the academic community (Ioannidis et al. 2014). 
 
Whom does this concern? 
Editors of scientific journals in orthodontics can actively encourage or even demand data sharing through 
the ‘Instructions for Authors’ website and their online manuscript submission system. This can be done by 
requiring authors to submit a data statement, including what data from the study are available, who can 
access the data (and how) and optimally, how to replicate the study results. This may be through uploading 
a dataset in an online open repository (Harvard Dataverse, Dryad, Mendeley Data, Zenodo) during 
manuscript submission, with the authors then providing the data set’s unique Digital Object Identifier (DOI) 
received from the repository, which is published together with the paper. Associate editors and peer-
reviewers need to be aware of the advantages of data sharing and check if this has been covered in the 
submission. Researchers submitting to journals should also be aware that editors may take into 
consideration data sharing statements and data availability when making editorial decisions. Finally, funding 
agencies and scientific societies funding orthodontic research can include data sharing as requirement for 
all grantees. 
 Sharing primary data will increase confidence in the conclusions of clinical studies, generate new 
hypotheses, make the most of what may be learned from each study, and enable independent confirmation 
of results, which is an essential tenet of the scientific process. In the end, data sharing helps fulfil our moral 
obligation to study participants, thereby benefiting, patients, researchers, clinicians, funding agencies and 
ultimately, society. 
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Table 1. List of general medicine and orthodontic journals and their policy regarding data sharing of research data  
Journal Data availability encouraged Mandatory 
Annals of Internal Medicine - 
Data statement published in paper (before 
References) 
Willingness to provide data for randomised 
trials 
British Medical Journal Data statement published in paper (before References) 
Data availability for randomised trials on 
request 
Journal of Clinical Epidemiology 
Upload dataset via submission system to a repository 
Linking dataset’s DOI in the submission system 
Data-availability banner in the published paper 
Data statement published in paper (before References) 
- 
New England Journal of Medicine - Data availability for microarray studies 
Journal of the American Medical 
Association 
Data statement published in paper (before References)  
Lancet 
Data statement including dataset’s DOI published in 
paper (Methods section) 
- 
Nature - 
Data statement published in paper (Methods 
section) and data availability in repository 
PLOS journals Data statement strongly recommended  - 
   
American Journal of Orthodontics and 
Dentofacial Orthopedics 
Linking dataset’s DOI in the submission system 
Data-availability banner in the published paper 
Data statement encouraged 
- 
European Journal of Orthodontics - - 
The Angle Orthodontist - - 
Journal of Clinical Orthodontics - - 
Journal of Orofacial Orthopedics Repository deposit encouraged - 
Korean Journal of Orthodontics - - 
Orthodontics & Craniofacial Research (only mention) - 
Journal of Orthodontics (only mention) - 
Journal of the World Federation of 
Orthodontists 
Linking dataset’s DOI in the submission system 
Data-availability banner in the published paper 
Data statement encouraged 
- 
Orthodontic Waves 
Linking dataset’s DOI in the submission system 
Data-availability banner in the published paper 
Data statement encouraged 
- 
Dental Press Journal of Orthodontics - - 
 
Table 2. List of funders for which clinical trial archiving is required (Hahnel, 2015) 
Funder When Country 
AHRC At the earliest possible opportunity UK 
Austrian Science Fund Immediately after publication of results Austria 
Bill and Melinda Gates Foundation Immediately after publication of results USA 
Biotechnology and Biological Sciences Research 
Council (BBSRC) 
Must be archived within 3 years after 
project completion 
UK 
Canadian Institutes of Health Research (CIHR) Immediately after publication of results Canada 
Cancer Research UK Immediately after publication of results UK 
Department for International Development (DFID) 
Must be archived within 12 months 
after project completion 
UK 
Economic and Social Research Council (ESRC) 
Must be archived within 3 months after 
project completion 
UK 
Engineering and Physical Sciences Research Council 
(EPSRC) 
At the earliest possible opportunity UK 
Fondazione Cariplo Not specified Italy 
Genome Canada Immediately after publication of results Canada 
Gordon and Betty Moore Foundation (GBMF) At the earliest possible opportunity USA 
Heart and Stroke Foundation of Canada (HSF) Immediately after publication of results Canada 
Higher Education Authority (HEA) 
Within a reasonable time after 
completion of the work 
Ireland 
Howard Hughes Medical Institute (HHMI) Immediately after publication of results USA 
Marie Curie Cancer Care Immediately after publication of results UK 
Medical Research Council (MRC) 
Within a reasonable time after 
completion of the work 
UK 
Michael Smith Foundation for Health Research 
(MSFHR) 
Immediately after publication of results Canada 
National Centre for the Replacement, Refinement 
and Reduction of Animals in Research (NC3Rs) 
Not specified UK 
National Institutes of Health (NIH) 
Within a reasonable time after 
completion of the work 
USA 
Natural Environment Research Council (NERC) 
Within a reasonable time after 
completion of the work 
UK 
Nuffield Foundation 
Must be archived within 1 year after 
project completion 
UK 
Ontario Institute for Cancer Research (OICR) At the earliest possible opportunity Canada 
Országos Tudományos Kutatási 
Alapprogramok (OTKA) 
Not specified Hungary 
Vetenskapsrådet 
Within a reasonable time after 
completion of the work 
Sweden 
Wellcome Trust Immediately after publication of results UK 
World Bank At the earliest possible opportunity 
United 
States 
 
